Otofarma SpA (MIL:OTO) EBIT: € Mil (TTM As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.80
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA EBIT?

Otofarma SpA MIL:OTO -0.71% 16 EBIT is € Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was €1.94 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Otofarma SpA's annualized ROC % for the quarter that ended in Dec. 2024 was 13.38%. Otofarma SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 50.51%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Otofarma SpA  (MIL:OTO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Otofarma SpA's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=1.935 * ( 1 - 58.66% )/( (5.827 + 6.128)/ 2 )
=0.799929/5.9775
=13.38 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8.218 - 1.493 - ( 0.898 - max(0, 3.562 - 5.649+0.898))
=5.827

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10.183 - 1.535 - ( 2.52 - max(0, 3.309 - 6.992+2.52))
=6.128

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Otofarma SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1.935/( ( (1.262 + max(2.265, 0)) + (1.402 + max(2.733, 0)) )/ 2 )
=1.935/( ( 3.527 + 4.135 )/ 2 )
=1.935/3.831
=50.51 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.433 + 0.199 + 1.119) - (1.493 + 0 + 0.993)
=2.265

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.536 + 0.157 + 0.779) - (1.535 + 0 + 0.204)
=2.733

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Otofarma SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=/17.022
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA EBIT Related Terms

Otofarma SpA EBIT Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA EBIT Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
EBIT
1.08 1.94

Otofarma SpA Semi-Annual Data
Dec23 Dec24
EBIT 1.08 1.94

MIL:OTO vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Otofarma SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Otofarma SpA EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Otofarma SpA's EV-to-EBIT falls into.


MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was € Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of € Mil mean?
Otofarma SpA (MIL:OTO) has a EBIT of € Mil as of Dec. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Otofarma SpA.
Is Otofarma SpA's EBIT too high?
Otofarma SpA's current EBIT is € Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's EBIT compare to ABT and SYK?
Otofarma SpA's EBIT of € Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Otofarma SpA. Otofarma SpA's current EBIT is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current EBIT of € Mil. The current EBIT is € Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current EBIT is € Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.80
Price